Location: Home
  • search
  • go
  • Relate News
  • 4/28/2022NMPA Holds Meeting to Review Vaccine Regulatory Quality Management Sys...
  • 4/28/2022Biotech Venture Capital Investment in China Climbs (WSJ)
  • 4/21/2022Legend Makes $50M Milestone under J&J Partnership Deal for Anticancer...
  • 4/20/2022Chugai Pharma Loses China's First Drug Patent Linkage Lawsuit
  • 4/12/2022Pfizer Wins Chinese Approval of JAK1 Inhibitor Abrocitinib for moderat...
  • 4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...
  • 4/6/2022Everest Med Enters into an MOU for Partnership with CR Pharma for its ...
  • 3/28/2022Upcoming Event: 5th European Meeting on Materials Science and Nanotech...
  • 3/28/2022BRICS Launches Vaccine R&D Center
  • 3/28/2022Fosun Pharma Hopes Covid Vaccine Can Cure Its Ailing Margins
  • 3/24/2022Fosun Reports Over CNY 1B of BioNTech mRNA Vaccine Sales in 2021 Despi...
  • 3/21/2022Bavarian Nordic and Nuance Pharma Enter License for RSV Vaccine for ...
  • 3/3/2022China Conditionally Approves First Recombinant Protein COVID-19 Vaccin...
  • 3/3/2022Domestic Chinese Checkpoint Inhibitors: A Big Threat to Western Pharm...
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • 2/16/2022SciNeuro and Alamar Collaborate to Discover Novel Therapeutic Antibodi...
  • 2/16/2022Organon Acquires Bayer's Contraceptive Products Marvelon and Mercilo...
  • 2/9/2022Zerun Bio and Walvax to Get Additional CEPI Funding for Vaccine to Pro...
  • 1/14/2022NMPA Announces Package Insert Revision of Cimetidine Injectable Formul...
  • 1/12/2022BioNTech Remains Committed to Seeking China Approval for COVID-19 Vacc...
  • 1/7/2022NMPA Approves MSD's Letermovir and Eli Lilly's Abemaciclib in China
  • 12/23/2021Luye Grants Genscience Chinese Commercialization Rights of Rivastigmin...
  • 12/23/2021Pfizer Gains Chinese Approval of ADC Drug Besponsa
  • 12/21/2021Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL
  • 12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
  • 12/17/2021Data Snapshot – The Landscape of Innovative Biologics in China
  • 12/15/2021New Study: China Healthcare under Remaking in Digital Era
  • 12/15/2021Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)
  • 12/14/2021Everest Med and Providence Therapeutics Join Hands to Co-develop Vacci...
  • Page:10/72 Total number of articles:2132: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group